sorafenib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1 (2)

Interventional (2)

Innovent Biologics (Suzhou) Co. Ltd. (1)
Shanghai Zhongshan Hospital (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadhepatocellular carcinoma

I am/have/hadcarcinoma

I am/have/hadunresectable hepatocellular carcinoma

I am/have/hadmicrowave ablation

added new label for I am/have/had

more

I am looking for

I am looking forTACE

I am looking forsintilimab

I am looking forpd-1 inhibitor

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Ib Study of the Efficacy and Safety of IBI310 Combined With Sintilimab in Advanced Hepatocellular Carcinoma

An open-label, single-arm, Ib study of the efficacy and safety of IBI310 combined with sintilimab in patients with advanced hepatocellular carcinoma

0 views
16 Feb, 2024
1 location

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.

Efficacy and Safety of Locoregional treatments Combined With PD-1 Inhibitor in Patients With Unresectable Hepatocellular Carcinoma.

carcinoma

unresectable hepatocellular carcinoma

TACE

sintilimab

pd-1 inhibitor

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.